SOURCE: CLX Investment Company, Inc.

January 15, 2008 09:43 ET

CLX Investment Company Announces New Director of Commercial Operations for Zonda Subsidiary

MURRIETA, CA--(Marketwire - January 15, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that Zonda's Director of European Sales Pavel Holik has been promoted to the position of Director of Commercial Operations. This position, which is inclusive of the duties of Mr. Holik's previous title, will also include business analysis, strategic planning, worldwide distribution, and oversight of manufacturing.

As Zonda prepares for the initiation of clinical trials for its rapid point of care test for Chlamydia as part of the process to achieve FDA clearance for the product, it has shifted the focus of its operation to the new Dallas office, where the office of Vera Leonard, President/CEO of both Zonda and CLX is located. Mr. Holik has relocated to the Dallas offices and has begun working with Safis Solutions, which is providing ongoing consulting services in the areas of regulatory approvals and quality systems for Zonda. CLX anticipates a mid-to-late first calendar quarter 2008 beginning for the clinical trials.

As CLX considers additional medical diagnostic products and technologies that may be acquired and/or licensed, Mr. Holik may be utilized for these initiatives as well.

Mr. Holik has worked with Zonda since late 2005 and was announced as the company's Director of European Sales in February 2006. His focus was on the establishment of distributor relationships in markets across Europe.

"Mr. Pavel Holik has proven himself to be an outstanding asset to Zonda through his work with the company's European distributors, and we are extremely confident that he will bring this same level of effectiveness to his new responsibilities," commented Ms. Leonard. "We are pleased that Pavel has made such a serious commitment to our efforts by moving his family to Dallas to work with us in Zonda's new corporate headquarters. His assistance will be a significant benefit to management as we implement our growth strategies for both CLX and Zonda."

Mr. Holik previously served as product manger and business analyst for a leading provider of electronic voting solutions. As general manager for a Czech airplane manufacturer, Mr. Holik established a North American sales and customer support office, negotiated exclusive sales and distribution contracts, and worked closely with investors and venture capital groups to grow the company. Before being assigned to establish the airline's North American office, Mr. Holik served as director of sales, aircraft sales manager and aircraft salesperson.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Investment Company

CLX Investment Company (www.clxinvestments.com) holds a 51% equity interest in Zonda, Inc. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    951-677-8073
    Email Contact